[1] Han S, Li T, Ellis E, Strom S, et al. A novel bile acidactivated vitamin D receptor signaling in human hepatocytes. Mol Endocrinol,2010,24:1151-1164.
[2] Jiang YJ, Teichert AE, Fong F, et al. 1α,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway. J Steroid Biochem Mol Biol,2013,136: 229-232.
[3] Ding N, Yu RT, Subramaniam N, et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.Cell,2013,153: 601-613.
[4] Barchetta I, Carotti S, Labbadia G,et al. Liver vitamin D receptor, CYP2R1, and CYP27A1expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology,2012, 56: 2180-2187.
[5] Black L J,Jacoby, P, She Ping-Delfos, et al. Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity. J. Gastroent. Hepatol,2014, 29:1215-1222.
[6] Roth CL,Elfers CT, Figlewicz D P,et al.Vitamin D deficiency In obese rats exacerbates nonalcoholic fatty liver disease and increases Hepatic resistin and Toll-like receptor activation.Hepatology,2012,55:1103-1111.
Abdelghany AH, BaSalamah MA,Idris S,et al.The fibrolytic potentials of vitamin D and thymoquinone remedial therapies: insights from liver fibrosisestablished by CCl4 in rats.J Transl Med,2016,29;14:281.
[7] Liangpunsakul S, Chalasani N. Serum vitamin D concentrations and unexplained elevation in ALT among US adults. Dig Dis Sci,2011,56: 2124-2129.
[8] Rhee EJ, Kim MK, Park SE, et al. High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr J,2013,60: 743-752.
[9] Targher G,Bertolini L,Scala L,et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis,2007,17: 517-524.
[10] Mohamed Ahmed A, Abdel Ghany M, Abdel Hakeem GL,et al.Assessment of Vitamin D status in a group of Egyptian children with non alcoholic fatty liver disease (multicenter study),2016,13:53-59.
[11] Hong HC, Lee JS, Choi HY, et al. Liver enzymes and vitamin D levels in metabolically healthy but obese individuals:Korean National Health and Nutrition Examination Survey.Metabolism,2013,62: 1305-1312.
[12] Ju SY, Jeong HS, Kim do H. Blood vitamin D status and metabolic syndrome in the general adult population: a dose response metaanalysis. J Clin Endocrinol Metab,2014,99: 1053-1063.
[13] Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology,2010,52: 1836-1846.
[14] Kasapoglu B,Turkay C,Yalcin KS,et al.Low vitamin D levels are associated with increased risk for fatty liver disease among non-obese adults.Clin Med,2013,13:576-579.
[15] Shojaei Zarghani S,Soraya H,Alizadeh M,et al. Calcium and vitamin D3 combinations improve fatty liver disease through AMPK-independent mechanisms,2016,17. [Epub ahead of print]
[16] Patel YA, Henao R, Moylan CA,et al.Vitamin D is Not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis.Am J Gastroenterol,2016,111:1591-1598.
[17] Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr,2011,65: 1005-1015.
[18] Cardoso-Sánchez LI, Gómez-Díaz RA, Wacher NH,et al. Vitamin D intake associates with insulin resistance in type 2 diabetes, but not in latent autoimmune diabetes in adults.Nutr Res,2015,35:689-699.
[19] George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance:a systematic review and meta analysis. Diabet Med,2012,29:e142-e150.
[20] Zeitz U, Weber K, Soegiarto DW, et al.Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J,2003,17: 509-511.
[21] Seida JC, Mitri J, Colmers IN, et al.Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta analysis. J Clin Endocrinol Metab,2014,99: 3551-3560.
[22] Papapostoli I, Lammert F, Stokes CS,et al.Effect of Short-Term Vitamin D Correction on Hepatic Steatosis as Quantified by Controlled Attenuation Parameter (CAP).J Gastrointestin Liver Dis,2016,25:175-181.
[23] Foroughi M, Maghsoudi Z, Askari G,et al.The effect of vitamin D supplementation on blood sugar and different Indices of insulin resistance in patients with non-alcoholic fatty liver disease(NAFLD).Iran J Nurs Midwifery Res,2016,21:100-104.
[24] Lorvand Amiri H, Agah S, Tolouei Azar J,et al.Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.Clin Nutr,2016,28.[Epub ahead of print]
[25] Barchetta I, Del Ben M, Angelico F,et al.No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.BMC Med,2016,14:92-102. |
